CUBE vs UPB · P/E 25, rev $1.07B vs rev $2.4M
CubeSmart (CUBE) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. UPB currently screens at market cap $407.3M.
Not investment advice. Open the CUBE and UPB stock pages for the full models.
Not investment advice.